StockWatch
·

Expleo Solutions Ltd Q1 FY27 Results

EXPLEOSOLQ1 FY27 Results
Filing
Result:GoodMargin expansion
MetricValueQ4 FY26Q1 FY26
Revenue291.55 Cr1.8%12.3%
Total Income298.48 Cr0.1%12.0%
Expenditure254.23 Cr1.7%6.7%
PBT44.24 Cr13.1%56.0%
Net Profit34.18 Cr18.0%67.3%
OPM14.53%1.12pp3.08pp
NPM11.45%2.49pp3.79pp
EPS22.0218.0%67.3%
View full financials

IT services: revenue grew a healthy 12.3% YoY with clean margin expansion (OPM 11.5%→14.5%, NPM 7.7%→11.5%) driving strong PAT growth, but growth was standalone-led while overseas subsidiaries shrank ~6.5% and no deal-win/guidance signals support a top-tier call.

Q1 FY-2027 RESULTS · EXPLEOSOL

Expleo Solutions Q1 FY27: consolidated PAT up 67% YoY on margin gains, down 18% QoQ

PAT +67.35% YoY · revenue +12.29% · margins expanding

14 Aug 2026 · 3 min read
Revenue

₹291.55 Cr

+12.29% YoY

PAT (consolidated)

₹34.18 Cr

+67.35% YoY

Net margin

11.45%

+3.8pp YoY

EPS

₹22.02

Expleo Solutions' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 12.3% YoY to ₹291.55 Cr (₹259.65 Cr a year ago), while consolidated PAT jumped 67.3% YoY to ₹34.18 Cr (₹20.43 Cr in Q1 FY26); EPS came in at ₹22.02 versus ₹13.16. Neither period carried exceptional items, so the YoY comparison is clean. Profitability outgrew revenue: OPM expanded to 14.53% from 11.45% and NPM to 11.45% from 7.66% a year earlier, aided by a lower effective tax rate (22.7% versus 28.0% in Q1 FY26).

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹291.55 Cr+1.8%+12.3%
Expenses₹254.23 Cr+1.7%+6.7%
PAT₹34.18 Cr-17.98%+67.35%
Net margin11.45%-2.5pp+3.8pp
EPS₹22.02-18%+67.3%

Sequentially, though, growth moderated: revenue was up just 1.8% QoQ and PAT fell 18.0% from ₹41.67 Cr in Q4 FY26, with OPM easing from 15.65% and NPM from 13.94%. Two factors explain the QoQ dip — Q4 FY26 carried a ₹2.06 Cr exceptional gain (Impact of New Labour Codes) that is absent this quarter, and other expenses rose to ₹62.55 Cr from ₹55.52 Cr even as revenue grew only modestly, pressuring the operating line.

758.52814.01869.5924.99980.48815.9505-1106-0406-3007-2308-14Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹815.95, up 1.9% over the past month of trading.

₹ Cr
015.5631.1146.6724.08Q4 FY25rev ₹256 Cr20.43Q1 FY26rev ₹260 Cr39.76Q2 FY26rev ₹283 Cr22.13Q3 FY26rev ₹279 Cr41.67Q4 FY26rev ₹286 Cr34.18Q1 FY27rev ₹292 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

Consolidated basic EPS ₹22.02 vs ₹13.16 YoY (+67.4%) — standalone EPS ₹18.78 vs ₹9.52 YoY

Standalone and consolidated tell different growth stories: standalone (India) PAT nearly doubled YoY (+97.3% to ₹29.14 Cr) on 15.5% revenue growth, while the combined overseas subsidiaries' revenue fell roughly 6.5% YoY and their profit contribution eased to ₹5.04 Cr from ₹5.66 Cr — consolidated PAT growth of 67.3% trails standalone because the overseas book is shrinking even as the India business scales. Management gives no formal guidance on record, and no analyst consensus estimates for this quarter turned up in a web search, so vs-guidance and vs-street are both unknown. Concurrently, the board recommended a ₹110/share final dividend for FY26 (approval due at the August 26, 2026 AGM) and incorporated a new GIFT IFSC subsidiary in India on June 14, 2026, which has yet to commence operations; separately, KMP Saket Newaskar's last working day was set for August 1, 2026, a management transition disclosed this quarter but unconnected to these numbers.

  • W1

    Whether other expenses (up to ₹62.55 Cr from ₹55.52 Cr QoQ) stay elevated or ease back in Q2 FY27

  • W2

    Overseas subsidiary revenue trajectory — down ~6.5% YoY this quarter, the key swing factor for consolidated growth

  • W3

    Effective tax rate sustainability: 22.7% this quarter vs 18.1% in Q4 FY26 and 28.0% a year ago

Informational and educational content only. Not investment advice.

Expleo Solutions Ltd (EXPLEOSOL) Q1 FY27 Results — StockWatch